Genome-wide (over)view on the actions of vitamin D

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chromatin; Epigenomics; Gene regulation; Genomics; Vitamin D; Vitamin D receptor

Indexed keywords

COLECALCIFEROL; ESTROGEN RECEPTOR ALPHA; LIVER X RECEPTOR; RNA POLYMERASE II; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR ESRRB; TRANSCRIPTION FACTOR GABPA; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

BINDING AFFINITY; BINDING SITE; CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; EPIGENETICS; GENE CONTROL; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MOLECULAR EVOLUTION; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SEASONAL VARIATION; SIGNAL TRANSDUCTION; SUN EXPOSURE; TRANSCRIPTION INITIATION SITE; UBIQUITINATION; VITAMIN METABOLISM;

EID: 84901048634     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00167     Document Type: Review

References (77)

1. Bouillon, R., and Suda, T. (2014). Vitamin D: calcium and bone homeostasis during evolution. Bonekey Rep. 3:480. doi: 10.1038/bonekey.2013.214
2. Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L. J., Grippo, J. F., and Hunziker, W. (1993). Two nuclear signalling pathways for vitamin D. Nature 361, 657-660.
3. Carlberg, C., and Campbell, M. J. (2013). Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78, 127-136. doi: 10.1016/j.steroids.2012.10.019
4. Carlberg, C., and Molnár, F. (2012). Current status of vitamin D signaling and its therapeutic applications. Curr. Top. Med. Chem. 12, 528-547. doi: 10.2174/156802612799436623
5. 3 supplementation. PLoS ONE 8:e71042. doi: 10.1371/journal.pone.0071042
6. Crawford, G. E., Holt, I. E., Whittle, J., Webb, B. D., Tai, D., Davis, S., et al. (2006). Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 16, 123-131. doi: 10.1101/gr.4074106
7. Deluca, H. F. (2004). Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80, 1689S-1696S.
8. Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., et al. (2013). A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613. doi: 10.1016/j.cell.2013.03.028
9. Encode-Project-Consortium, Bernstein, B. E., Birney, E., Dunham, I., Green, E. D., Gunter, C., and Snyder, M. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74. doi: 10.1038/nature11247
10. Engelman, C. D., Fingerlin, T. E., Langefeld, C. D., Hicks, P. J., Rich, S. S., Wagenknecht, L. E., et al. (2008). Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J. Clin. Endocrinol. Metab. 93, 3381-3388. doi: 10.1210/jc.2007-2702
11. 3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site. J. Steroid Biochem. Mol. Biol. 103, 440-445. doi: 10.1016/j.jsbmb.2006.11.018
12. Fullwood, M. J., Liu, M. H., Pan, Y. F., Liu, J., Xu, H., Mohamed, Y. B., et al. (2009). An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 462, 58-64. doi: 10.1038/nature08497
13. Furey, T. S. (2012). ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions. Nat. Rev. Genet. 13, 840-852. doi: 10.1038/nrg3306
14. Giresi, P. G., Kim, J., McDaniell, R. M., Iyer, V. R., and Lieb, J. D. (2007). FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res. 17, 877-885. doi: 10.1101/gr.5533506
15. Handel, A. E., Sandve, G. K., Disanto, G., Berlanga-Taylor, A. J., Gallone, G., Hanwell, H., et al. (2013). Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Med 11:163. doi: 10.1186/1741-7015-11-163
16. Haussler, M. R., Haussler, C. A., Jurutka, P. W., Thompson, P. D., Hsieh, J. C., Remus, L. S., et al. (1997). The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J. Endocrinol. 154(Suppl.), S57-S73.
17. Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J.-C., and Jurutka, P. W. (2013). Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77-98. doi: 10.1007/s00223-012-9619-0
18. 3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 39, 9181-9193. doi: 10.1093/nar/gkr654
19. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., et al. (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589. doi: 10.1016/j.molcel.2010.05.004
20. Hochberg, Z., and Templeton, A. R. (2010). Evolutionary perspective in skin color, vitamin D and its receptor. Hormones (Athens) 9, 307-311. doi: 10.14310/horm.2002.1281
21. Holick, M. F. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80, 1678S-1688S.
22. Holick, M. F. (2007). Vitamin D deficiency. N. Engl. J. Med. 357, 266-281. doi: 10.1056/NEJMra070553
23. Holick, M. F. (2011). Vitamin D: evolutionary, physiological and health perspectives. Curr. Drug Targets 12, 4-18. doi: 10.2174/138945011793591635
24. Hollis, B. W. (2005). Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135, 317-322.
25. Institute-of-Medicine. (2011). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press.
26. Jones, G., Strugnell, S. A., and Deluca, H. F. (1998). Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78, 1193-1231.
27. Kadauke, S., and Blobel, G. A. (2009). Chromatin loops in gene regulation. Biochim. Biophys. Acta 1789, 17-25. doi: 10.1016/j.bbagrm.2008.07.002
28. 3 is mediated through multiple long-range enhancers. Mol. Cell Biol. 26, 6469-6486. doi: 10.1128/MCB.00353-06
29. 3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine beta-synthase. J. Bone Miner. Res. 26, 2991-3000. doi: 10.1002/jbmr.493
30. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
31. Maston, G. A., Landt, S. G., Snyder, M., and Green, M. R. (2012). Characterization of enhancer function from genome-wide analyses. Annu. Rev. Genomics Hum. Genet. 13, 29-57. doi: 10.1146/annurev-genom-090711-163723
32. 3. J. Biol. Chem. 285, 15599-15610. doi: 10.1074/jbc.M110.119958
33. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2012). VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 26, 37-51. doi: 10.1210/me.2011-1109
34. 3 in intestinal cells. Mol. Endocrinol. 20, 1447-1461. doi: 10.1210/me.2006-0031
35. Misteli, T. (2007). Beyond the sequence: cellular organization of genome function. Cell 128, 787-800. doi: 10.1016/j.cell.2007.01.028
36. Mohn, F., and Schubeler, D. (2009). Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet. 25, 129-136. doi: 10.1016/j.tig.2008.12.005
37. Molnár, F., Peräkylä, M., and Carlberg, C. (2006). Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J. Biol. Chem. 281, 10516-10526. doi: 10.1074/jbc.M513609200
38. Moras, D., and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384-391.
39. Narlikar, G. J., Fan, H. Y., and Kingston, R. E. (2002). Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487. doi: 10.1016/S0092-8674(02)00654-2
40. Norman, A. W. (2008). From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 88, 491S-499S.
41. Orlando, V. (2000). Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem. Sci. 25, 99-104. doi: 10.1016/S0968-0004(99)01535-2
42. Orton, S. M., Morris, A. P., Herrera, B. M., Ramagopalan, S. V., Lincoln, M. R., Chao, M. J., et al. (2008). Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 88, 441-447.
43. Park, P. J. (2009). ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 10, 669-680. doi: 10.1038/nrg2641
44. Perissi, V., Jepsen, K., Glass, C. K., and Rosenfeld, M. G. (2010). Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11, 109-123. doi: 10.1038/nrg2736
45. 3 receptor-corepressor partnership. FASEB J. 14, 1455-1463. doi: 10.1096/fj.14.10.1455
46. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20, 1352-1360. doi: 10.1101/gr.107920.110
47. Razin, A. (1998). CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 17, 4905-4908.
48. Robinson, J. T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., and Mesirov, J. P. (2011). Integrative genomics viewer. Nat. Biotechnol. 29, 24-26. doi: 10.1038/nbt.1754
49. 3 target genes in a human myeloid leukemia cell line. Cancers 5, 1221-1241. doi: 10.3390/cancers5041221
50. 3 receptor. Nucleic Acids Res. 34, 543-554. doi: 10.1093/nar/gkj460
51. 3. J. Biol. Chem. 284, 8073-8082. doi: 10.1074/jbc.M808090200
52. Schmidt, D., Schwalie, P. C., Wilson, M. D., Ballester, B., Gonçalves, A., Kutter, C., et al. (2012). Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell 148, 335-348. doi: 10.1016/j.cell.2011.11.058
53. Schüle, R., Umesono, K., Mangelsdorf, D. J., Bolado, J., Pike, J. W., and Evans, R. M. (1990). Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61, 497-504.
54. Seuter, S., Neme, A., and Carlberg, C. (2014). Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. PLoS ONE 9. doi: 10.1371/journal.pone.0096184
55. Seuter, S., Pehkonen, P., Heikkinen, S., and Carlberg, C. (2013). Dynamics of 1α,25-dihydroxyvitamin D-dependent chromatin accessibility of early vitamin D receptor target genes. Biochim. Biophys. Acta 1829, 1266-1275. doi: 10.1016/j.bbagrm.2013.10.003
56. Seuter, S., Väisänen, S., Radmark, O., Carlberg, C., and Steinhilber, D. (2007). Functional characterization of vitamin D responding regions in the human 5-lipoxygenase gene. Biochim. Biophys. Acta 1771, 864-872. doi: 10.1016/j.bbalip.2007.04.007
57. Shaffer, P. L., and Gewirth, D. T. (2002). Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J. 21, 2242-2252. doi: 10.1093/emboj/21.9.2242
58. Shaffer, P. L., and Gewirth, D. T. (2004). Structural analysis of RXR-VDR interactions on DR3 DNA. J. Steroid Biochem. Mol. Biol. 89-90, 215-219. doi: 10.1016/j.jsbmb.2004.03.084
59. 3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell Biol. 23, 3339-3351. doi: 10.1128/MCB.23.9.3339-3351.2003
60. 3-responsive regions in its promoter. Nucleic Acids Res. 33, 2440-2451. doi: 10.1093/nar/gki502
61. Snellman, G., Melhus, H., Gedeborg, R., Olofsson, S., Wolk, A., Pedersen, N. L., et al. (2009). Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS ONE 4:e7747. doi: 10.1371/journal.pone.0007747
62. Sone, T., Ozono, K., and Pike, J. W. (1991). A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endocrinol 5, 1578-1586.
63. Standahl Olsen, K., Rylander, C., Brustad, M., Aksnes, L., and Lund, E. (2013). Plasma 25 hydroxyvitamin D level and blood gene expression profiles: a cross-sectional study of the Norwegian women and cancer post-genome cohort. Eur. J. Clin. Nutr. 67, 773-778. doi: 10.1038/ejcn.2013.53
64. Talbert, P. B., and Henikoff, S. (2006). Spreading of silent chromatin: inaction at a distance. Nat. Rev. Genet. 7, 793-803. doi: 10.1038/nrg1920
65. Tolon, R. M., Castillo, A. I., Jimenez-Lara, A. M., and Aranda, A. (2000). Association with ets-1 causes ligand- and AF2-independent activation of nuclear receptors. Mol. Cell Biol. 20, 8793-8802. doi: 10.1128/MCB.20.23.8793-8802.2000
66. 3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol. 400, 284-294. doi: 10.1016/j.jmb.2010.05.031
67. Tuoresmäki, P., Väisänen, S., Neme, A., Heikkinen, S., and Carlberg, C. (2014). Patterns of genome-wide VDR locations. PLoS ONE 9. doi: 10.1371/journal.pone.0096105
68. 3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res 35, 2734-2747. doi: 10.1093/nar/gkm179
69. 3 receptors. Cell 65, 1255-1266.
70. 3. J. Mol. Biol. 350, 65-77. doi: 10.1016/j.jmb.2005.04.057
71. Van Bortle, K., and Corces, V. G. (2013). The role of chromatin insulators in nuclear architecture and genome function. Curr. Opin. Genet. Dev. 23, 212-218. doi: 10.1016/j.gde.2012.11.003
72. Vaquerizas, J. M., Kummerfeld, S. K., Teichmann, S. A., and Luscombe, N. M. (2009). A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 10, 252-263. doi: 10.1038/nrg2538
73. Virtanen, J. K., Nurmi, T., Voutilainen, S., Mursu, J., and Tuomainen, T. P. (2011). Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur. J. Nutr. 50, 305-312. doi: 10.1007/s00394-010-0138-3
74. Wang, Y., Zhu, J., and Deluca, H. F. (2012). Where is the vitamin D receptor? Arch. Biochem. Biophys. 523, 123-133. doi: 10.1016/j.abb.2012.04.001
75. Zaret, K. S., and Carroll, J. S. (2011). Pioneer transcription factors: establishing competence for gene expression. Gen. Dev. 25, 2227-2241. doi: 10.1101/gad.176826.111
76. 3. Mol. Endocrinol. 20, 1231-1247. doi: 10.1210/me.2006-0015
77. Zella, L. A., Meyer, M. B., Nerenz, R. D., Lee, S. M., Martowicz, M. L., and Pike, J. W. (2010). Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 24, 128-147. doi: 10.1210/me.2009-0140